Rockefeller University clinical trials
Listed in the registry as: University, hospital or other organization.
The registry lists 122 studies whose lead sponsor is Rockefeller University. 2 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 13, 2026.
Keep track of what changes. Save the Rockefeller University studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesFocus areas
Conditions Rockefeller University leads ten or more studies in, by study count. A broader condition is left out when almost all its studies are already in a narrower one listed here.
Studies
Recruiting first, then most recently updated. Showing 50 of 122. Browse all 122 →
- Predictors of Aspirin Failure in Preeclampsia PreventionRecruitingNCT05709483Early Phase 1
- The Genetics and Functional Basis of Inherited Platelet, White Blood Cell, Red Blood Cell, and Blood Clotting Disorders.RecruitingNCT00230165
- HepB mAb19 in Individuals With Chronic Hepatitis B InfectionActive, not recruitingNCT05856890Phase 1
- Thermogenic Silencer Regulatory Factors in HumansActive, not recruitingNCT06424132Not applicable
- Yellow Fever Immune Response at Single Cell ResolutionCompletedNCT03458780
- BATokines as Biomarkers of Brown Fat in HumansActive, not recruitingNCT05050240Not applicable
- 3BNC117-LS First-in-Human Phase 1 StudyCompletedNCT03254277Phase 1
- HBV Vaccination of Healthy Volunteers to Evaluate the Composition of Germinal CentersTerminatedNCT05272735Phase 4
- Discovering the Antecedents of Rheumatoid Arthritis FlareActive, not recruitingNCT02051114
- Compassion-Based Resiliency Training (CBRT) Intervention on Racism-based StressCompletedNCT06146218Not applicable
- 3BNC117-LS and 10-1074-LS Plus N-803 (bNAb+N-803)CompletedNCT05245292Phase 1
- Effect of Antibiotics on Enteric Neurons and GliaCompletedNCT05834036Phase 4
- The Impact of Time Restricted Eating on Type 2 DiabetesTerminatedNCT06887543Not applicable
- 3BNC117 and 10-1074 in ART-treated IndividualsCompletedNCT03526848Phase 1
- RU Anti-SARS-CoV-2 (COVID-19) mAbs in Healthy VolunteersCompletedNCT04700163Phase 1
- Myokine Identification Following Acute ExerciseCompletedNCT06223035Not applicable
- An Open Label Study of IgG Fc Glycan Composition in Human ImmunityTerminatedNCT01967238Early Phase 1
- A Study Investigating the Safety and Tolerability of an Immune Treatment in Cancer Patients With Lesions to the SkinCompletedNCT04059588Phase 1
- Immunotherapy of the Paraneoplastic SyndromesCompletedNCT00378326Not applicable
- 3BNC117-LS and 10-1074-LS in Viremic HIV-infected IndividualsCompletedNCT04250636Phase 1
- Exploratory Study of Melatonin Induced Sleep Regularization in Severe Brain InjuryTerminatedNCT02732288Not applicable
- Diagnostic Imaging Study for the Melanoma Advanced Imaging Dermatoscope (mAID)CompletedNCT02470273
- Racism-based and Biomarkers of StressCompletedNCT05574933
- Time-Restricted FeedingCompletedNCT04884659Not applicable
- Molecular Characteristics of Brodalumab in Hidradenitis SuppurativaCompletedNCT04979520Early Phase 1
- Romidepsin Plus 3BNC117 Phase 2a StudyCompletedNCT02850016Phase 2
- When the Kidney Reacts to Nutritional ChangesCompletedNCT04142138Not applicable
- First-in-human Study of 10-1074-LS Alone and in Combination With 3BNC117-LSCompletedNCT03554408Phase 1
- A Study of the Safety and Antiretroviral Activity of 3BNC117CompletedNCT02588586Phase 2
- Effects of Dietary Fructose on Gut Microbiota and Fecal Metabolites in Obese Men and Postmenopausal Women: A Pilot StudyCompletedNCT03339245Not applicable
- Study of the Drug Efalizumab (Raptiva), for Adult Patients With Moderate to Severe Plaque PsoriasisCompletedNCT00115076Phase 3
- Psoriasis Inflammation and Systemic Co MorbiditiesCompletedNCT01170715Not applicable
- Celecoxib Inhibition of Aromatase Expression and Inflammation in Adipose Tissue of Obese Postmenopausal WomenCompletedNCT01901679Early Phase 1
- DASH Diet Intervention at Senior CentersCompletedNCT03993808Not applicable
- An Alternative Dose Interval Study in Participants With Hidradenitis Suppurativa Receiving BrodalumabWithdrawnNCT04249713Early Phase 1
- 3BNC117 Monoclonal Antibody in HIV-infected Subjects During Treatment InterruptionCompletedNCT02446847Phase 2
- Biomarkers in Participants With Hidradenitis Suppurativa Receiving Guselkumab.WithdrawnNCT04084665Early Phase 1
- Study of the Reversibility of Glucose Intolerance Caused by Chronic Aspartame ConsumptionCompletedNCT02520258Not applicable
- Biomarkers In Hidradenitis Suppurativa Participants Receiving BrodalumabCompletedNCT03960268Early Phase 1
- Effects of Persistent Innate Immune Activation on Vaccine EfficacyTerminatedNCT02429583Phase 4
- Impact of Narrowband UVB Phototherapy on Systemic Inflammation in Patients With Atopic DermatitisCompletedNCT03083730Not applicable
- Effects of Chronic Viral Infection on Immune Response to Zoster VaccinationTerminatedNCT02590068Not applicable
- Immunologic Effects of HCV Therapy With HARVONI in HCV Genotype 1 Chronically Mono-infected Active and Former IDUsCompletedNCT02347345Phase 4
- Randomized Placebo Controlled Study to Determine Safety, Pharmacodynamics and Efficacy of ILV-094 in Atopic DermatitisCompletedNCT01941537Phase 2
- Study to Evaluate Immune Responses in Neurologically Normal Cancer PatientsCompletedNCT00481637
- The Study of Immune Cell (T Cell) Activity in Patients With Paraneoplastic Neurologic SyndromesCompletedNCT00327236
- Viral and Host Factors in the Transmission and Pathogenesis of HIVTerminatedNCT00219947
- Weight Loss Using a Feedback Device in Obese People With the Metabolic SyndromeWithdrawnNCT03491930Not applicable
- Resveratrol and the Metabolic SyndromeCompletedNCT01714102Not applicable
- 3BNC117 and 10-1074 in HIV-infected IndividualsCompletedNCT02825797Phase 1